FDA Clears Expanded Indications for SINEFIX Orthopedic Implant Across Multiple Soft Tissue Repair Applications
Key Insights
The FDA has approved expanded clinical applications for Inovedis Inc. (search)'s SINEFIX (search) implant, extending its use beyond small rotator cuff tears to include procedures across shoulder, hip, knee, elbow, and foot/ankle repairs.
SINEFIX (search)'s innovative PEEK-based design distributes compression across a broad surface area rather than concentrating force through sutures, maintaining blood circulation critical for biological healing.
Surgeons report the device reduces procedure time by one-third for gluteal repairs and eliminates the complexity of suture management while preserving tendon integrity during repair.
Inovedis Inc. (search) announced that the U.S. Food and Drug Administration has cleared expanded clinical applications for the SINEFIX (search) Implant, positioning the orthopedic device as a versatile alternative to traditional suture anchors for soft tissue (search)-to-bone fixation across multiple anatomical sites.
The Minneapolis-based orthopedic company's flagship product can now be used for a comprehensive range of procedures including rotator cuff repairs and deltoid repair in the shoulder, Achilles tendon repair in the foot and ankle, multiple ligament and tendon repairs in the knee, various tendon reattachment procedures in the elbow, and gluteus medius and minimus repairs in the hip.
Innovative Design Addresses Traditional Fixation Limitations
SINEFIX (search) is composed of polyether ether ketone (PEEK) and includes one baseplate and two PEEK anchors equipped with additional teeth to prevent tendon slippage. The device's innovative design addresses key limitations of traditional fixation methods by distributing compression across a broad surface area rather than relying on sutures that can concentrate force and cut through tendon.
"Rather than relying on sutures that can concentrate force and cut through tendon, SINEFIX (search) secures tissue by distributing compression across a broad surface area, effectively 'stapling' the tendon to bone," according to the company. This approach eliminates point-loading of sutures and distributes pressure evenly across the repair footprint while maintaining blood circulation at the repair site, which is critical to biological healing.
Clinical Benefits Demonstrated Across Procedures
Christopher Dougherty, DO, reported significant procedural advantages with the device: "Using SINEFIX (search) for gluteal repairs cuts down the procedure time by one-third compared to a standard repair since there is no suture sorting. It is far faster and better than the standard technique. Plus, the biggest advantage is that you don't have to disrupt the tendon to fix it unlike other repair methods. Ideally, the goal is to preserve the tendon."
Michael R. Redler, MD, emphasized the technology's impact on rotator cuff repair: "SINEFIX (search) is a really exciting new technology that addresses the many challenges with rotator cuff repair. Its use with TendoGrip allows for controlled tensioning and improved footprint coverage in a streamlined approach, without the complexity of suture management. No other system lets you tension and insert in one step. Expanding its indication across all tear sizes further enhances its utility in soft tissue (search) repair."
Market Expansion and Future Applications
Lukas Floess, CEO and Co-founder of Inovedis, expressed satisfaction with meeting surgeon demand: "We are extremely happy to be able to meet the demand from surgeons to utilize SINEFIX (search) in these extended indications. Surgeons are no longer limited to using SINEFIX for small rotator cuff tears, and the prospects for its potential adoption in other areas of the body are considerable. This is a significant achievement for the company, and we look forward to advancing this technology in other areas of sports medicine and orthopedics."
The expanded indications represent a significant milestone for Inovedis, which positions itself as a cutting-edge medical technology company dedicated to offering innovative solutions that improve patient outcomes while minimizing the complexity of surgical interventions. SINEFIX (search) was originally designed to transform rotator cuff repair by addressing both biomechanical fixation and the critical role of blood flow in tendon-to-bone healing.
With the newly cleared clinical indications spanning multiple anatomical regions, SINEFIX (search) expands its reach across a wide range of orthopedic and sports medicine applications. The device is approved for sale in the United States.